Identification of Prognostic Genes in Acute Myeloid Leukemia Microenvironment: A Bioinformatic and Experimental Analysis
Molecular Biotechnology · 2025
DOI: 10.1007/s12033-024-01128-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Biotechnology, 2025. Verfasst von Ali Keshavarz und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and Blood Banking, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, P.O. Box: 15468-15514,…. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Tumor Microenvironment, Computational Biology, Biomarkers, Tumor. Die Arbeit nennt 36 Literaturangaben.
Abstract (Originalsprache)
Acute myeloid leukemia (AML) is a lethal hematologic malignancy with a variable prognosis that is highly dependent on the bone marrow microenvironment. Consequently, a better understanding of the AML microenvironment is crucial for early diagnosis, risk stratification, and personalized therapy. In recent years, the role of bioinformatics as a powerful tool in clarifying the complexities of cancer has become more prominent. Gene expression profile and clinical data of 173 AML patients were downloaded from the TCGA database, and the xCell algorithm was applied to calculate the microenvironment score (MS). Then, the correlation of MS with FAB classification, and CALGB cytogenetic risk category was investigated. Differentially expressed genes (DEGs) were identified, and the correlation analysis of DEGs with patient survival was done using univariate cox. The prognostic value of candidate prognostic DEGs was confirmed based on the GEO database. In the last step, real-time PCR was used to compare the expression of the top three prognostic genes between patients and the control group. During TCGA data analysis, 716 DEGs were identified, and survival analysis results showed that 152 DEGs had survival-related changes. In addition, the prognostic value of 31 candidate prognostic genes was confirmed by GEO data analysis. Finally, the expression analysis of FLVCR2, SMO, and CREB5 genes, the most related genes to patients' survival, was significantly different between patients and control groups. In summary, we identified key microenvironment-related genes that influence the survival of AML patients and may serve as prognostic and therapeutic targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology and Blood Banking, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, P.O. Box: 15468-15514, Tehran, Iran.
- Department of Laboratory Sciences, School of Paramedicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
- HSCT Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Department of Hematology and Blood Banking, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, P.O. Box: 15468-15514, Tehran, Iran. Allahbakhshian@sbmu.ac.ir.
Zitieren
APA
Keshavarz, A., Navidinia, A. A., Kuhestani Dehaghi, B. H., Amiri, V., Mohammadi, M. H., & Allahbakhshian Farsani, M. (2025). Identification of Prognostic Genes in Acute Myeloid Leukemia Microenvironment: A Bioinformatic and Experimental Analysis. Molecular Biotechnology. https://doi.org/10.1007/s12033-024-01128-3
Vancouver
Keshavarz A, Navidinia AA, Kuhestani Dehaghi BH, Amiri V, Mohammadi MH, Allahbakhshian Farsani M. Identification of Prognostic Genes in Acute Myeloid Leukemia Microenvironment: A Bioinformatic and Experimental Analysis. Molecular Biotechnology. 2025. doi:10.1007/s12033-024-01128-3
BibTeX
@article{Keshavarz2025,
author = {Keshavarz, Ali and Navidinia, Amir Abbas and Kuhestani Dehaghi, Bentol Hoda and Amiri, Vahid and Mohammadi, Mohammad Hossein and Allahbakhshian Farsani, Mehdi},
title = {Identification of Prognostic Genes in Acute Myeloid Leukemia Microenvironment: A Bioinformatic and Experimental Analysis},
journal = {Molecular Biotechnology},
year = {2025},
doi = {10.1007/s12033-024-01128-3}
}
EUVIMED